|
Online edition of India's National Newspaper Sunday, June 24, 2001 |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home |
|
Southern States
| Previous
| Next
Anti-rabies vaccine unit staff launch stir
By T. Lalith Singh
HYDERABAD, JUNE 23.
Even as the State Government sits on a proposal for closing down
the Anti-Rabies Vaccine (ARV) unit of the Institute of Preventive
Medicine (IPM), the 600-odd employees have launched an agitation
protesting against the move. The staff which started relay hunger
strike threatened on Saturday to intensify the agitation if the
Government failed to scrap the proposal for shutting down the 25-
year-old unit.
The employees accuse the Government of trying to take over the
58-acre land in which the ARV unit is located at Nacharam and
either retrench or redeploy the staff in other departments. The
unit produces around 15 lakh ml of ARV every year for attending
to dog bite cases and is supplied free of cost.
"If IPM stops production, where will the poor persons bitten by
dogs go for a vaccine ? The vaccines marketed by the
pharmaceutical companies cost around Rs. 1,800 for a course of
six injections. Would the poor be able to afford this cost ?"
argues Mr. P.Ram Narayan, president of the A.P.Medical Employees
Union, IPM-Unit. The IPM Anti Rabies clinic at Narayanguda alone
attends to an average of 550 dog bite cases every day.
The employees refuse to accept responsibility for the unit's
failure in reaching targets. "Agreed that we failed to reach the
target of 25 lakh ml per year, but authorities should take the
blame for this. The unit continues to be run on an annual budget
that was decided some 15 years ago," says the union treasurer,
Mr. P.Venkateswarulu. The ARV is developed from sheep brain and
the cost of sheep itself has gone up by at least 10 times in the
last 15 years, he says.
On Saturday, about 252 employees affiliated to the Andhra Pradesh
N.G.O's Association also joined the agitation. Interestingly,
even as the agitation threatened to pick heat, the IPM director,
Dr. P. Sangram, proceeded on leave on Friday and Mr. Alok
Srivastava, Inspector-General (Drugs & Copy Right), took over as
incharge director on Saturday morning. This move has caused
concern among the employees amidst rumours of their immediate
redeployment to other departments.
Faced with hostile employees, Mr.Srivastava, however, says that
the whole episode was "perhaps a result of misunderstanding". The
Government has not taken any decision so far and only a proposal
for closing down the unit was made following refusal of the Drug
Controller-General of India to renew it's licence.
"The unit's infrastructure is antiquated and the Drug Controller
has refused to renew the licence until certain modifications
(costing an estimated Rs. 55 lakhs) were carried out," he says.
Also, the World Health Organisation (WHO) has suggested that the
Government do away with the present Neural Tissue vaccine and
instead produce the latest Cell Culture vaccine which is known
for less side-effects.
"The question is whether to invest such an amount in a vaccine
(Neural Tissue) that is out dated or instead set up
infrastructure for the production of Cell Culture vaccine," Mr.
Srivastava questions.
The IPM Nacharam unit incharge, Dr. Lakshmi Prasad, feels that
Cell Culture vaccine which is prepared from cell lines minimises
the prospect of reaction to the patients and was also easy to
administer. "The present vaccine which is based on nearly
century-old concept involves the painful procedure of
administering in umbilical region. The new vaccine can be given
in deltoid (shoulder) region and the side effects are very rare
when compared to the present vaccine with one reaction in 10,000
injections," says Dr. Lakshmi Prasad.
The IPM incharge director, Mr. Srivastava, who held a meeting
with the agitating employees on Saturday afternoon sought to
impress upon them that there would not be any retrenchments. He
later told "The Hindu" that the "service and salaries of all the
employees would be protected in case the Government takes a
decision on stopping the vaccine production." Even the present
practice of providing free vaccine for dog bites would be
continued but with a "better Cell Culture vaccine."
Send this article to Friends by E-Mail
|
|
Section : Southern States Previous : Governor stresses R&D Next : CVC unveils three-point plan to fight corruption | |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home | |
|
Copyrights © 2001 The Hindu Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu |
|